[DPHARMA] QoQ Annualized Quarter Result on 30-Jun-2022 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Jun-2022 [#2]
Profit Trend
QoQ- -9.81%
YoY- 10.9%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 801,900 696,717 726,342 735,366 743,764 639,175 658,308 14.07%
PBT 113,168 84,851 92,672 96,238 106,584 82,983 87,808 18.44%
Tax -22,636 -14,739 -22,070 -23,034 -25,420 -17,300 -21,185 4.51%
NP 90,532 70,112 70,601 73,204 81,164 65,683 66,622 22.70%
-
NP to SH 90,532 70,112 70,601 73,204 81,164 65,683 66,622 22.70%
-
Tax Rate 20.00% 17.37% 23.82% 23.93% 23.85% 20.85% 24.13% -
Total Cost 711,368 626,605 655,741 662,162 662,600 573,492 591,685 13.07%
-
Net Worth 666,567 657,045 647,522 634,375 621,987 621,564 612,147 5.84%
Dividend
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Div - 21,901 6,348 9,468 - 21,660 6,278 -
Div Payout % - 31.24% 8.99% 12.93% - 32.98% 9.42% -
Equity
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Net Worth 666,567 657,045 647,522 634,375 621,987 621,564 612,147 5.84%
NOSH 952,239 952,239 952,239 952,239 941,765 941,765 941,765 0.74%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 11.29% 10.06% 9.72% 9.95% 10.91% 10.28% 10.12% -
ROE 13.58% 10.67% 10.90% 11.54% 13.05% 10.57% 10.88% -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
RPS 84.21 73.17 76.28 77.67 80.12 67.87 69.90 13.23%
EPS 9.52 7.39 7.45 7.76 8.76 6.98 7.08 21.84%
DPS 0.00 2.30 0.67 1.00 0.00 2.30 0.67 -
NAPS 0.70 0.69 0.68 0.67 0.67 0.66 0.65 5.06%
Adjusted Per Share Value based on latest NOSH - 952,239
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
RPS 83.30 72.37 75.45 76.39 77.26 66.40 68.38 14.07%
EPS 9.40 7.28 7.33 7.60 8.43 6.82 6.92 22.67%
DPS 0.00 2.28 0.66 0.98 0.00 2.25 0.65 -
NAPS 0.6924 0.6825 0.6726 0.659 0.6461 0.6457 0.6359 5.84%
Price Multiplier on Financial Quarter End Date
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Date 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 -
Price 1.56 1.61 1.30 1.20 1.49 1.68 1.81 -
P/RPS 1.85 2.20 1.70 1.55 1.86 2.48 2.59 -20.11%
P/EPS 16.41 21.87 17.53 15.52 17.04 24.09 25.59 -25.65%
EY 6.09 4.57 5.70 6.44 5.87 4.15 3.91 34.40%
DY 0.00 1.43 0.51 0.83 0.00 1.37 0.37 -
P/NAPS 2.23 2.33 1.91 1.79 2.22 2.55 2.78 -13.67%
Price Multiplier on Announcement Date
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Date 22/05/23 23/02/23 09/11/22 16/08/22 17/05/22 15/02/22 18/11/21 -
Price 1.44 1.65 1.39 1.34 1.51 1.60 1.62 -
P/RPS 1.71 2.26 1.82 1.73 1.88 2.36 2.32 -18.41%
P/EPS 15.15 22.41 18.75 17.33 17.27 22.94 22.90 -24.09%
EY 6.60 4.46 5.33 5.77 5.79 4.36 4.37 31.66%
DY 0.00 1.39 0.48 0.75 0.00 1.44 0.41 -
P/NAPS 2.06 2.39 2.04 2.00 2.25 2.42 2.49 -11.88%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment